Literature DB >> 30426496

Epidemiology and outcomes of acute kidney injury in hospitalized cancer patients in China.

Yichun Cheng1, Sheng Nie2, Lu Li3, Yanqin Li2, Diankun Liu2, Mengqi Xiong2, Long Wang2, Shuwang Ge1, Gang Xu1.   

Abstract

Acute kidney injury (AKI) is a common complication in cancer patients, but the data are lacking in Asian countries. We aimed to assed the epidemiology, correlated risk factors and outcomes of AKI in cancer patients from China. We conducted a nationwide cohort study of cancer patients who were admitted to 25 general and children hospitals across China from January 1, 2013 to December 31, 2015. We obtained patient-level data from the electronic hospitalization information system and laboratory databases of all inpatients who had at least two serum creatinine tests within any 7-day window during their first 30 days of hospitalization. AKI was defined and staged according to Kidney Disease Improving Global Outcomes criteria. Incidence rate and risk factor profiles for AKI were examined. Outcomes of interest included in-hospital mortality, length of stay and daily costs. A total of 136,756 adult cancer patients were assessed in our study. The overall incidence of AKI was 7.5%, of which 1.6% were community acquired and 5.9% hospital acquired. The top three cancer types with high incidence of AKI were bladder cancer, leukemia, and lymphoma. Risk factors for community-acquired and hospital-acquired AKI were similar, including age, increased baseline serum creatinine, shock and urinary tract obstruction. In-hospital death occurred in 12.0% with AKI vs. 0.9% cancer patients without AKI. After adjustment for confounders, the severe AKI was associated with higher risk of in-hospital death, prolonged length of stay and higher daily costs. Clinicians should increase their awareness of AKI in hospitalized cancer patients.
© 2018 UICC.

Entities:  

Keywords:  KDIGO AKI criteria; acute kidney injury; cancer patients; incidence

Mesh:

Substances:

Year:  2019        PMID: 30426496     DOI: 10.1002/ijc.31993

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Early, empiric high-dose leucovorin rescue in lymphoma patients treated with sequential doses of high-dose methotrexate.

Authors:  Jason N Barreto; Kristen T Peterson; Erin F Barreto; Kristin C Mara; Ross A Dierkhising; Nelson Leung; Thomas E Witzig; Carrie A Thompson
Journal:  Support Care Cancer       Date:  2021-03-04       Impact factor: 3.603

Review 2.  Acute kidney injury in cancer patients.

Authors:  Shuiying Liu; Jinyuan Zhao; Feng Wang
Journal:  Clin Exp Nephrol       Date:  2021-09-09       Impact factor: 2.801

3.  The Effect of Admission Serum Magnesium on the Acute Kidney Injury Among Patients with Malignancy.

Authors:  Daoqi Shen; Yimei Wang; Jiarui Xu; Yang Li; Xiaohong Chen; Man Guo; Xuemei Geng; Xiaoqiang Ding; Xialian Xu
Journal:  Cancer Manag Res       Date:  2020-08-11       Impact factor: 3.989

4.  A cross-sectional study of chemotherapy-related AKI.

Authors:  Xin Kang; Xizi Zheng; Damin Xu; Tao Su; Ying Zhou; Jing Ji; Qi Yu; Yimin Cui; Li Yang
Journal:  Eur J Clin Pharmacol       Date:  2021-05-15       Impact factor: 2.953

5.  hsa_circ_0139402 Promotes Bladder Cancer Progression by Regulating hsa-miR-326/PAX8 Signaling.

Authors:  Bo Wei; Zunxian Wang; Qixin Lian; Baojin Chi; Shuxia Ma
Journal:  Dis Markers       Date:  2022-02-01       Impact factor: 3.434

6.  An unusual case of acute kidney injury caused by obstructive uropathy revealing gastric cancer.

Authors:  Karima Boubaker; Mohamad Alkadi; Omar Fitouri; Ali Ibrahim Ali Rahil; Hassen Al Malki
Journal:  Qatar Med J       Date:  2022-03-04

Review 7.  Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI.

Authors:  Letizia De Chiara; Gianmarco Lugli; Gianluca Villa; Valentina Raglianti; Faeq Husain-Syed; Fiammetta Ravaglia; Paola Romagnani; Elena Lazzeri
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

8.  Comparative Risk of Renal Adverse Events in Patients Receiving Immune Checkpoint Inhibitors: A Bayesian Network Meta-Analysis.

Authors:  Kang Liu; Zhongke Qin; Xueqiang Xu; Ting Li; Yifei Ge; Huijuan Mao; Changying Xing
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

Review 9.  Acute Kidney Injury in the Patient with Cancer.

Authors:  Alejandro Meraz-Munoz; Amit Langote; Kenar D Jhaveri; Hassane Izzedine; Prakash Gudsoorkar
Journal:  Diagnostics (Basel)       Date:  2021-03-29

Review 10.  Management of acute kidney injury in gastrointestinal tumor: An overview.

Authors:  Yi-Qi Su; Yi-Yi Yu; Bo Shen; Feng Yang; Yu-Xin Nie
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.